Celldex Therapeutics reported $10.36M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agenus USD 71.08M 11.9M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Celldex Therapeutics USD 10.36M 9.18M Mar/2026
Glaxosmithkline GBP 20.72B 346.14M Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Northwest Biotherapeutics 36.72M 9.49M Sep/2025
Pfizer USD 4.51B 734M Mar/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025